Publications
39
Citations
1,108
Est. group size
~9
Recurring co-author estimate
Active years
11
Publishing since 2016
Typically publishes in teams of ~5 · 18% small-team papers (≤3 authors) · across 18 venues
- Nintedanib attenuates profibrotic gene expression in a 3-dimensional organotypic culture model of systemic sclerosis skin fibrosis
Journal of Investigative Dermatology · 2026
- Inhibiting Neuropilin-1 as a novel therapeutic approach to mitigate pulmonary fibrosis: Highlighting the potential anti-fibrotic effects of ATWLPPR peptide
International Immunopharmacology · 2025
- Epithelial Deletion of Perk Reduces Lung Injury and Fibrosis in Multiple in Vivo Models of Epithelial Dysfunction and Lung Injury
American Journal of Respiratory and Critical Care Medicine · 2025
- 599 Selective inhibition Of fibro-inflammatory kinase TAK1: A potential therapeutic strategy to ameliorate systemic sclerosis
Journal of Investigative Dermatology · 2022
- Natural product topical therapy in mitigating imiquimod-induced psoriasis-like skin inflammation-underscoring the anti-psoriatic potential of Nimbolide
Indian Journal of Pharmacology · 2021
- Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo
Toxicology and Applied Pharmacology · 2020
- Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
Cell Death and Disease · 2019
- Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases
Drug Delivery and Translational Research · 2019
- Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study
Life Sciences · 2019
- Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-β1 driven epithelial-to-mesenchymal transition
International Immunopharmacology · 2019
- Protective Effects of Nanoceria in Imiquimod Induced Psoriasis by Inhibiting The Inflammatory Responses
Nanomedicine · 2019
- An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
Frontiers in Pharmacology · 2018
- Synthesis of 1,2,4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents
Bioorganic & Medicinal Chemistry Letters · 2018
- Withaferin <scp>A</scp>, a novel compound of <scp>I</scp>ndian ginseng (<scp><i>Withania somnifera</i></scp>), ameliorates <scp>C</scp>erulein‐induced acute pancreatitis: Possible role of oxidative stress and inflammation
Phytotherapy Research · 2018
- Withaferin A attenuates bleomycin‐induced scleroderma by targeting FoxO3a and NF‐κβ signaling: Connecting fibrosis and inflammation
BioFactors · 2018
- Journal of Investigative Dermatology×5
- JCI Insight×4
- iScience×2
- Phytotherapy Research×2
- International Immunopharmacology×2
- John Varga
Medicine · University of Michigan
- Swati Bhattacharyya
Medicine · University of Michigan
- Pei‐Suen Tsou
Medicine · University of Michigan
- Dinesh Khanna
Medicine · University of Michigan
- Dinesh Khanna
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile